Establishes tianeptine as Schedule II controlled dangerous substance.
Impact
If passed, A4814 would necessitate significant changes to the legal framework surrounding tianeptine. The bill introduces stricter penalties for the manufacture, distribution, and possession of the drug. Manufacturing or distributing tianeptine in quantities of one ounce or more would be classified as a second-degree crime, punishable by 5 to 10 years in prison and substantial fines. In contrast, lesser quantities would result in third-degree crime charges, carrying sentences of 3 to 5 years. Furthermore, it would become illegal to possess tianeptine, with penalties extending to possible imprisonment and fines depending on the nature of the violation.
Summary
Assembly Bill A4814 proposes the classification of tianeptine as a Schedule II controlled dangerous substance in the state of New Jersey. This change arises from concerns regarding the drug's potential for abuse and addiction, similar to that of opioids. Tianeptine, primarily used as an antidepressant, has been shown to produce opioid-like effects, leading to its categorization alongside narcotic drugs that can lead to severe psychological or physical dependence.
Contention
The bill reflects broader societal concerns about the epidemic of substance abuse and the need for enhanced regulatory measures regarding potentially dangerous drugs. Supporters argue that classifying tianeptine as a controlled substance is crucial for safeguarding public health and preventing addiction. In contrast, opponents may raise concerns regarding access to legitimate medical uses of tianeptine and the potential for patients reliant on the drug to face difficulties in receiving necessary treatment.
Controlled substances: other; sentencing guidelines for retail sale of products containing ephedrine or pseudoephedrine; modify. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 4947'25